Sign in

CIK 0001728117

  • Non-accelerated filer
  • Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475461709
Phone
+1 858-684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-23 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2026-09-23 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2026-09-23 Ciongoli Gregory Austin Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2026-09-23 Drynan Skye Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2026-09-23 Quisel John D Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2026-09-23 Cox Russell J. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2026-09-23 Nathan Steven D Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2026-08-24 Smith Robert Paul JR Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +5,800,051 5,800,051
2026-08-24 Peterson Caryn Chief Development Officer Grant or award · Stock Option (Right to Buy) +5,800,051 5,800,051
2026-08-24 Giraudo Bryan COO/CFO Grant or award · Pre-Funded Warrant (Right to Buy) +25 $1,000.00 $25K 25
2026-08-24 Giraudo Bryan COO/CFO Grant or award · Stock Option (Right to Buy) +5,800,051 5,800,051
2026-08-24 Christian Waage EVP, Tech Ops and Admin Grant or award · Stock Option (Right to Buy) +2,900,026 2,900,026
2026-08-24 Hasnain Faheem President & CEO Grant or award · Pre-Funded Warrant (Right to Buy) +166 $1,000.00 $166K 166
2026-08-24 Hasnain Faheem President & CEO Grant or award · Stock Option (Right to Buy) +5,800,051 5,800,051
2026-06-04 Nathan Steven D Director Grant or award · Stock Option (Right to Buy) +115,000 115,000
2026-06-04 Drynan Skye Director Grant or award · Stock Option (Right to Buy) +115,000 115,000
2026-06-04 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +115,000 115,000
2026-06-04 Quisel John D Director Grant or award · Stock Option (Right to Buy) +115,000 115,000
2026-06-04 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +115,000 115,000
2026-06-04 Cox Russell J. Director Grant or award · Stock Option (Right to Buy) +115,000 115,000

Page 1 of 21 · 417 trades